Cancer risk rises in arthritis drug study | Chicago Tribune

Rheumatoid arthritis patients taking Abbott Laboratories' blockbuster drug Humira or Johnson & Johnson's Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a new study found.

Breaking News: BioAdvance Invests In Midway Pharmaceuticals to Support Promising Development Program for GI Therapies

BioAdvance Investment Recognizes Potential of Midway's Proprietary Polymer MDY-1001 to Treat Disorders Including Crohn's Disease and Ulcerative Colitis

Acquisition of OnFiber Communications could save Qwest $25 million in access costs while extending its metro Ethernet network.

Qwest Communications said Monday it will buy privately owned OnFiber in a $107 million deal that could help the Denver-based telecom company compete nationally with the giants.

DenverPost.com - Qwest's stand wins praise

Qwest's reported refusal to give its customer calling records to the National Security Agency is winning the Denver-based phone company big fans online.

Chron's could be caused by bacteria -- Newsday.com

On a chilly Tuesday night in late March, reason enough not to brave the cold, officials at the Suffolk Y Jewish Community Center in Commack were stunned when their auditorium overflowed with 700 people.

Qwest buys OnFiber

Qwest Communications is extending its out-of-region reach and revenue with the acquisition of metro Ethernet provider OnFiber Communications for $107 million.

Chron.com | (BW) Qwest to Acquire OnFiber Communications, Inc.

DENVER--(BUSINESS WIRE)--May 15, 2006--Qwest Communications International Inc. (NYSE: Q) announced today that it will acquire privately held OnFiber Communications, Inc., an Austin-based provider of custom-built and managed metropolitan Ethernet and wide-area network solutions.

Qwest Goes From the Goat to the Hero - New York Times

FEW customers are given to gushing about their phone companies, but before last week's report that Qwest Communications was apparently the lone holdout among the Big Four telecommunications companies secretly supplying the National Security Agency with call records on ordinary Am

Stock Market News and Investment Information | Reuters.com

NEW YORK, May 15 (Reuters) - Local telephone operator Qwest Communications International Inc. (Q.N: Quote, Profile, Research) said on Monday it agreed to buy privately held communications network operator OnFiber Communications Inc.

Qwest to keep speeding on Web

Denver-based Qwest Communications has big plans, after announcing a return to profitability Wednesday.

Jurors duped, Nacchio says Experts call the filing by the former Qwest CEO "an attempt to put the prosecution on trial."

Former Qwest chief executive Joe Nacchio accused prosecutors Monday of misleading grand jurors when the government sought an indictment against him last year.

Brussels shares higher midmorning; UCB up as market downplays Cimzia study - Forbes.com

BRUSSELS (AFX) - Shares were higher midmorning on sentiment boosted by overnight Wall Street gains, with UCB in positive territory as the market downplayed the impact of phase three study results on the pharmaceutical group's Crohn's disease drug Cimzia, which prompted a broker

Schering-Plough Quarterly Earnings Triple - Forbes.com

Schering-Plough Corp. on Thursday said its profit more than tripled in the first quarter behind strong sales of the cholesterol drugs Vytorin and Zetia, and its top-seller, the rheumatoid arthritis drug Remicade. Its shares rose more than 2 percent. ..

Sentence could be adjusted for former Qwest executive

DENVER Prosecutors may adjust the sentence for a former Qwest Communications executive, who pleaded guilty to an accessory count in a 34-(m)-million-dollar fraud scheme.

Pension fund pulls out of settlement with Qwest

A large pension fund has withdrawn from a $400 million class-action shareholder settlement with Qwest Communications, but it's unclear whether any others will follow suit.

Osiris Completes Enrollment in Stem Cell Trial to Treat Cardiac Disease

Stem cells to treat Crohn's Disease... I was not aware of this one... they are in a Phase II trial already.

Remicade Set for Priority Review

Johnson & Johnson's Remicade drug received priority-review status for treating Crohn's disease in children.

Centocor seeking more approvals for its flagship product - 2006-04-03

With no new products on the immediate horizon, Centocor Inc. is banking on the expanded use of its flagship product to continue its revenue growth this year.

SEC Must Refile Two Civil Claims Against Nacchio

DENVER (AP)--A federal judge on Thursday dismissed two claims the Securities and Exchange Commission made in its civil fraud lawsuit against former Qwest Communications International Inc.

Qwest Communications International CEO Got $3.15 Million Bonus For 2005

Qwest Communications International Inc. (Q) (Q) said Thursday that Chairman and Chief Executive Richard C. Notebaert got a $3.15 million bonus for 2005, up from his 2004 bonus of $2.97 million.

Will Vonage go public or sell out?

Vonage filed to go public nearly two months ago but it has yet to file any amended registration statements with the Securities and Exchange Commission.

Peptech bets on antibody disease cure - Business - Business - theage.com.au

DRUG developer Peptech says developing antibodies is the way into the future, even though biotechnology licensing deals are sometimes "like pulling a rabbit out of a hat".

Crohn's Patient, Recently Undergoing Life Threatening Surgery, Launches Website To Help Others With Crohn's Disease

The new website is a website developed by a Crohn's disease patient and victim of serious medical malpractice.

Belgium's UCB has a new drug to fight Crohn's and other diseases.

BLOCKBUSTER TO BE? UCB's most exciting new drug is Cimzia. The antibody-based medicine is being targeted initially at people with Crohn's disease, a chronic inflammatory disorder of the digestive tract that affects nearly 1 million patients worldwide. If the U.S.

REMICADE(R) Is Approved in Australia for Treatment of Early Rheumatoid Arthritis and Psoriatic Arthritis | Nachrichten | Aktienkurs |

Thursday afternoon, Schering-Plough Corp. , announced that its drug REMICADE, in combination with methotrexate has been approved in Australia, for the treatment of early rheumatoid

Latest Comments

    Profile

    bennernet

    Articles Posted: 0
    Links Seeded: 37
    Member Since: 2/2006Last Seen: 2/01/2007

    bennernet has not filled out a bio yet.

    bennernet's Friends

    bennernet's Feeds

    Subscribe to bennernet's content using the feeds below. Use RSS for your newsreader and JSS to insert onto your own blog:
    • Articles
    • Seeds